EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distribution of Human Papillomavirus Genotypes in Real‐World Cervical Self‐Collected Scrapings From the Dutch Cervical Cancer Screening Program

Kelly Melisa Castañeda iD, Jolien de Waard, Lorian Slagter-Menkema, Mirjam Mastik, Floris Adriaan Vuijk, Rudolf Lambertus Maria Bekkers, Geertruida Hendrika de Bock, Gijsbertha Barendina Alida Wisman, Ed Schuuring

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Kelly Melisa Castañeda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Genotype, Papillomavirus Infections, Uterine Cervical Neoplasms, Papillomaviridae. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by CC Diagnostics, MSD B.V., Abbott Molecular Inc., The Ministry of Science, Technology, and Innovation of Colombia, and the Netherlan….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐risk HPV (hrHPV) is the necessary cause of cervical cancer with HPV16/18 accounting for around 70% of the cases worldwide, while other non‐HPV16/18 hrHPV genotypes prevail in ~95% of high‐grade lesions. Understanding regional genotype distribution of hrHPV types not covered by the nonavalent vaccine is crucial for evaluating vaccine effectiveness and enhancing population‐based screening (PBS). The objective of the present study is to update hrHPV genotype prevalence in a non‐vaccinated cohort of 1200 hrHPV‐positive women from the Dutch PBS using INNO‐LiPA HPV Genotyping Extra‐II to identify 32 individual HPV genotypes in self‐sampled material. HrHPV prevalence for all 32 genotypes, also grouped by bivalent, quadrivalent, and nonavalent vaccine types (2vHPV, 4vHPV, and 9vHPV), was reported by histologic diagnosis and age. The most common genotypes were HPV16 (394,33%), especially in younger women, followed by HPV31 (216,18%) and HPV52 (199,17%). 2vHPV genotypes were found in 23% ( n = 90) of NILM cases, 27% ( n = 84) of CIN0/CIN1, 45% ( n = 74) of CIN2, 71% ( n = 219) of CIN3, and 92% ( n = 12) of cervical cancers. In comparison, 9vHPV genotypes appeared in 60% ( n = 240) of NILM, 69% ( n = 218) of CIN0/CIN1, 88% ( n = 145) of CIN2, 94% ( n = 289) of CIN3, and all cervical cancers ( n = 13). HrHPV types not included in 9vHPV had an overall prevalence of 19% ( n = 225), with 88% (197/225) found in NILM or CIN0/CIN1. This study highlights vaccine‐type HPV in all cancer cases and many high‐grade lesions, reinforcing the need for improved vaccination efforts and broader protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GenotypePapillomavirus InfectionsUterine Cervical NeoplasmsPapillomaviridaeCervix UteriHumansFemaleNetherlandsMiddle AgedAdultEarly Detection of CancerPrevalenceAgedYoung AdultHuman Papillomavirus Viruses

Stichwörter der Autor:innen

human papillomavirus virusesprevalenceuterine cervical neoplasms

Autor:innen und Institutionen

  • Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Department of Gynecologic Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
  • Department of Otorhinolaryngology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • MSD B.V., Haarlem, the Netherlands.
  • Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, Nijmegen, the Netherlands.

ORCID-Profile: Kelly Melisa Castañeda

Förderung

  • This study was supported by CC Diagnostics, MSD B.V., Abbott Molecular Inc., The Ministry of Science, Technology, and Innovation of Colombia, and the Netherlan…

Zitieren

APA

Castañeda, K. M., de Waard, J., Slagter-Menkema, L., Mastik, M., Vuijk, F. A., Bekkers, R. L. M., de Bock, G. H., Wisman, G. B. A., & Schuuring, E. (2025). Distribution of Human Papillomavirus Genotypes in Real‐World Cervical Self‐Collected Scrapings From the Dutch Cervical Cancer Screening Program. Journal of Medical Virology. https://doi.org/10.1002/jmv.70461

Vancouver

Castañeda KM, de Waard J, Slagter-Menkema L, Mastik M, Vuijk FA, Bekkers RLM, et al. Distribution of Human Papillomavirus Genotypes in Real‐World Cervical Self‐Collected Scrapings From the Dutch Cervical Cancer Screening Program. Journal of Medical Virology. 2025. doi:10.1002/jmv.70461

BibTeX
@article{Castaeda2025,
  author = {Castañeda, Kelly Melisa and de Waard, Jolien and Slagter-Menkema, Lorian and Mastik, Mirjam and Vuijk, Floris Adriaan and Bekkers, Rudolf Lambertus Maria and de Bock, Geertruida Hendrika and Wisman, Gijsbertha Barendina Alida and Schuuring, Ed},
  title = {Distribution of Human Papillomavirus Genotypes in Real‐World Cervical Self‐Collected Scrapings From the Dutch Cervical Cancer Screening Program},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70461}
}
Kostenlos starten →